Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -96,460 | -289,088 | -250,739 | -141,164 | -69,214 |
| Depreciation Amortization | -2,285 | 4,737 | 5,895 | 5,639 | 2,922 |
| Accounts payable and accrued liabilities | -231 | 2,373 | -527 | -1,150 | -1,252 |
| Other Working Capital | -42,480 | 236,158 | 247,316 | 250,646 | 259,511 |
| Other Operating Activity | 31,641 | 68,347 | 89,773 | 52,243 | 26,523 |
| Operating Cash Flow | $-109,815 | $22,527 | $91,718 | $166,214 | $218,490 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,017 | -48,951 | -40,690 | -28,903 | -7,259 |
| Purchase Of Investment | -266,532 | -1,616,999 | -1,378,609 | -1,020,578 | -690,390 |
| Sale Of Investment | 298,000 | 1,204,614 | 844,524 | 510,880 | 160,310 |
| Investing Cash Flow | $25,451 | $-461,336 | $-574,775 | $-538,601 | $-537,339 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 99,081 | 114,065 | 81,409 | 79,243 | 56,235 |
| Other Financing Activity | -665 | -2,475 | -1,831 | -1,227 | -559 |
| Financing Cash Flow | $98,416 | $111,590 | $79,578 | $78,016 | $55,676 |
| Beginning Cash Position | 245,521 | 572,740 | 572,740 | 572,740 | 572,740 |
| End Cash Position | 259,573 | 245,521 | 169,261 | 278,369 | 309,567 |
| Net Cash Flow | $14,052 | $-327,219 | $-403,479 | $-294,371 | $-263,173 |
| Free Cash Flow | |||||
| Operating Cash Flow | -109,815 | 22,527 | 91,718 | 166,214 | 218,490 |
| Capital Expenditure | -6,017 | -48,951 | -40,690 | -28,903 | -7,259 |
| Free Cash Flow | -115,832 | -26,424 | 51,028 | 137,311 | 211,231 |